Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 24;25(1):286.
doi: 10.3390/ijms25010286.

Structure and Neuroprotector Properties of a Complex Compound of Lithium with Comenic Acid

Affiliations

Structure and Neuroprotector Properties of a Complex Compound of Lithium with Comenic Acid

Stanislav Kozin et al. Int J Mol Sci. .

Abstract

The structure, antioxidant and neuroprotective properties of lithium comenate (lithium 5-hydroxy-4-oxo-4H-pyran-2-carboxylate) were studied. Lithium comenate was obtained by reacting comenic acid (H2Com) with lithium hydroxide in an aqueous solution. The structure of lithium comenate was confirmed via thermal analysis, mass spectrometry, IR, NMR and UV spectroscopy. The crystal structure was studied in detail via X-ray diffraction. The compound crystallized in a non-centrosymmetric space group of symmetry of the orthorhombic system Pna21 in the form of a hydrate, with three water molecules entering the first coordination sphere of the cation Li+ and one molecule forming a second environment through non-valent contacts. The gross formula of the complex compound was established [Li(HCom)(H2O)3]·H2O. It has been established that lithium comenate has a pronounced neuroprotective activity under the excitotoxic effect of glutamate, increasing the survival rate of cultured rat cerebellar neurons more than two-fold. It has also been found that the pre-stress use of lithium comenate at doses of 1 and 2 mg/kg has an antioxidant effect, which is manifested in a decrease in oxidative damage to the brain tissues of mice subjected to immobilization stress. Based on the data available in the literature, we believe that the high neuroprotective and antioxidant efficacy of lithium comenate is a consequence of the mutual potentiation of the pharmacological effects of lithium and comenic acid.

Keywords: antioxidant; comenic acid; excitotoxicity; gamma-pyrones; lithium; lithium comenate; lithium complex compounds; neuroprotection.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Structural formulas of common γ-pyrones: 1—kojic acid, 2—comenic acid, 3—meconic acid, 4—chelidonic acid, 5—maltol.
Figure 2
Figure 2
Scheme for preparation of lithium comenate (6).
Figure 3
Figure 3
General view of a molecule of a complex compound of lithium with 5-hydroxy-4-oxo-4H-pyran-2-carboxylic acid in a crystal. Lithium atom is colored yellow, carbons are black and white, hydrogens are white, and oxygens are red.
Figure 4
Figure 4
Non-valent intermolecular contacts.
Figure 5
Figure 5
Effect of lithium comenate (LiCom, a) and lithium chloride (LiCl, b) on neuronal survival after exposure to glutamate (Glu). * p < 0.05 in relation to control, # p < 0.05 in relation to Glu.
Figure 6
Figure 6
Effect of lithium comenate (LiCom) on the intraneuronal Ca2+ level after excitotoxic exposure to glutamate (Glu). * p < 0.05 in relation to control, # p < 0.05 in relation to Glu.
Figure 7
Figure 7
Effect of lithium comenate on chemiluminescence intensity (ChL) and malondialdehyde (MDA) content in the brains of stressed mice during pre-stress application. * p < 0.05 in relation to control, # p < 0.05 in relation to stress.

References

    1. Rybakowski J. Lithium treatment–the state of the art for 2020. Psychiatr. Pol. 2020;54:1047–1066. doi: 10.12740/PP/128340. - DOI - PubMed
    1. Rakofsky J.J., Lucido M.J., Dunlop B.W. Lithium in the treatment of acute bipolar depression: A systematic review and meta-analysis. J. Affect. Disord. 2022;308:268–280. doi: 10.1016/j.jad.2022.04.058. - DOI - PubMed
    1. Wen J., Sawmiller D., Wheeldon B., Tan J. A Review for Lithium: Pharmacokinetics, Drug Design, and Toxicity. CNS Neurol. Disord. Drug. Targets. 2019;18:769–778. doi: 10.2174/1871527318666191114095249. - DOI - PubMed
    1. Öhlund L., Ott M., Oja S., Bergqvist M., Lundqvist R., Sandlund M., Salander Renberg E., Werneke U. Reasons for lithium discontinuation in men and women with bipolar disorder: A retrospective cohort study. BMC Psychiatry. 2018;18:37. doi: 10.1186/s12888-018-1622-1. - DOI - PMC - PubMed
    1. Pacholko A.G., Bekar L.K. Lithium orotate: A superior option for lithium therapy? Brain Behav. 2021;11:e2262. doi: 10.1002/brb3.2262. - DOI - PMC - PubMed